Colorectal Cancer
Experts
Subscribe today and get credible, unbiased information from disease experts sent straight to your phone or inbox.
Rana McKay, MD shares the data from the CARD trial for advanced metastatic castration resistant prostate cancer (CRPC). She discusses the endpoints of the trial including image based PFS.
“(This trial) does suggest that sequence matters…and it changes the treatment landscape.
Subscribe today and get credible, unbiased information from disease experts sent straight to your phone or inbox.
Contact us to join our network, learn more about our educational offerings, or inquire about joining our faculty. We are your source for up-to-date clinical information.
GET IN TOUCH
Rana R. McKay, MD is an Associate Professor of Medicine at the University of California San Diego and Co-Leader of the Genitourinary Oncology Disease Team at the Moores Cancer Center. She is a board-certified medical oncologist who specializes in treating people with urogenital cancers, including bladder, kidney, prostate, and testicular cancer. Her research interests include the design and implementation of clinical trials to advance the treatment of patients with urologic cancers. She serves as the Principal Investigator of several early phase trials in kidney and prostate cancer. As a clinical investigator, she is committed to advancements that will improve the lives of individuals with cancer. Furthermore, she is interested in understanding mechanisms of response and resistance to specific cancer therapies. Her work has appeared in peer-reviewed publications such as the Nature, Lancet, Journal of Clinical Oncology, Clinical Cancer Research, Cancer, among others. Dr. McKay earned her medical degree at the University of Florida College of Medicine before completing her residency in Internal Medicine at Johns Hopkins Hospital. She completed a fellowship in Oncology/Hematology at the Dana-Farber Cancer Institute, Harvard Medical School. She went on to serve as an Assistant Professor at Harvard Medical School and a medical oncologist at Dana-Farber/Brigham and Women’s Cancer Center in Boston before joining UC San Diego Health.